HRMY Q4 2025 Earnings — Harmony Biosciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena

HRMYHarmony Biosciences Holdings, Inc.

$2B

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$244M+21.1% YoY

Gross Profit

$175M71.9% margin

Operating Income

$39M15.8% margin

Net Income

$22M9.2% margin

EPS (Diluted)

$0.38

QoQ Revenue Growth

+1.8%

Cash Flow

Operating Cash Flow

$126M

Free Cash Flow

$126M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$401M

Stockholders' Equity

$870M

Cash & Equivalents

$753M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$244M	$201M	+21.1%
Gross Profit	$175M	$147M	+19.3%
Operating Income	$39M	$56M	-30.8%
Net Income	$22M	$49M	-54.6%